Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $266,570 | 22 | 84.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,668 | 7 | 7.9% |
| Travel and Lodging | $12,068 | 44 | 3.8% |
| Consulting Fee | $7,863 | 1 | 2.5% |
| Food and Beverage | $2,885 | 67 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aesculap Biologics, LLC | $309,645 | 99 | $0 (2024) |
| Stryker Corporation | $3,752 | 21 | $0 (2018) |
| Nevro Corp. | $151.36 | 2 | $0 (2019) |
| Zimmer Biomet Holdings, Inc. | $110.49 | 3 | $0 (2019) |
| Smith+Nephew, Inc. | $96.10 | 3 | $0 (2019) |
| Nalu Medical, Inc. | $56.72 | 3 | $0 (2022) |
| Bioventus LLC | $53.99 | 3 | $0 (2022) |
| Siemens Medical Solutions USA, Inc. | $50.56 | 1 | $0 (2022) |
| Vericel Corporation | $48.40 | 2 | $0 (2023) |
| Boston Scientific Corporation | $27.39 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,154 | 5 | Aesculap Biologics, LLC ($51,154) |
| 2023 | $183,420 | 18 | Aesculap Biologics, LLC ($183,395) |
| 2022 | $34,145 | 13 | Aesculap Biologics, LLC ($34,036) |
| 2021 | $12,061 | 14 | Aesculap Biologics, LLC ($12,041) |
| 2020 | $5,286 | 21 | Aesculap Biologics, LLC ($5,234) |
| 2019 | $5,698 | 14 | Aesculap Biologics, LLC ($5,444) |
| 2018 | $14,307 | 29 | Aesculap Biologics, LLC ($13,030) |
| 2017 | $7,984 | 27 | Aesculap Biologics, LLC ($5,310) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $6,500.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 06/20/2024 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $31,396.00 | Research |
| Study: SAFETY AND EFFICACY OF NOVOCART 3D IN THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS FOLLOWING FAILURE ON MICROFRACTURE • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 06/20/2024 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $8,293.50 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 06/20/2024 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $4,896.00 | Research |
| Study: SAFETY AND EFFICACY OF NOVOCART 3D IN THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS FOLLOWING FAILURE ON MICROFRACTURE • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 06/11/2024 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | Food and Beverage | Cash or cash equivalent | $68.54 | General |
| Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 12/13/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $10,020.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 12/13/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $990.00 | Research |
| Study: SAFETY AND EFFICACY OF NOVOCART 3D IN THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS FOLLOWING FAILURE ON MICROFRACTURE • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 12/06/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $62,425.61 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 12/06/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $7,849.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 11/22/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $11,389.20 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 11/22/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $6,250.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 11/22/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $2,800.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 11/22/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $721.80 | Research |
| Study: SAFETY AND EFFICACY OF NOVOCART 3D IN THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS FOLLOWING FAILURE ON MICROFRACTURE • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 10/09/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | Food and Beverage | Cash or cash equivalent | $32.77 | General |
| Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 05/10/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | Food and Beverage | Cash or cash equivalent | $51.87 | General |
| Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 05/03/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $2,176.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 04/26/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $1,536.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 04/19/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $1,971.00 | Research |
| Study: SAFETY AND EFFICACY OF NOVOCART 3D IN THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS FOLLOWING FAILURE ON MICROFRACTURE • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 04/05/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $53,396.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 04/05/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $14,836.20 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 04/05/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $4,100.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 04/05/2023 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $2,850.00 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
| 03/29/2023 | Vericel Corporation | MACI (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Orthopedics | ||||||
| 12/21/2022 | Bioventus LLC | Exogen Ultrasound Bone Healing System (Device) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Not Applicable | ||||||
| 10/19/2022 | Aesculap Biologics, LLC | NOVOCART 3D (Device) | — | Cash or cash equivalent | $27,706.20 | Research |
| Study: NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) • Category: CARTILAGE REPAIR AND REGENERATION | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) | Aesculap Biologics, LLC | $225,528 | 16 |
| SAFETY AND EFFICACY OF NOVOCART 3D IN THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS FOLLOWING FAILURE ON MICROFRACTURE | Aesculap Biologics, LLC | $41,042 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 134 | 184 | $76,805 | $19,785 |
| 2022 | 10 | 286 | 346 | $107,811 | $27,352 |
| 2021 | 16 | 465 | 577 | $162,505 | $42,299 |
| 2020 | 18 | 679 | 865 | $312,933 | $76,697 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 27447 | Replacement of knee joint, both sides of knee | Office | 2023 | 14 | 14 | $48,906 | $13,275 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 24 | $9,528 | $2,039 | 21.4% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 29 | 41 | $3,608 | $1,183 | 32.8% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 31 | 49 | $3,724 | $1,107 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $4,320 | $1,025 | 23.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 17 | $6,075 | $952.38 | 15.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 11 | 23 | $644.00 | $204.11 | 31.7% |
| 27447 | Replacement of knee joint, both sides of knee | Office | 2022 | 15 | 15 | $51,480 | $13,556 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 38 | $15,224 | $3,617 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 46 | $12,420 | $2,592 | 20.9% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 61 | 77 | $6,776 | $2,142 | 31.6% |
| 73560 | X-ray of knee, 1-2 views | Office | 2022 | 59 | 72 | $5,472 | $1,665 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,400 | $1,362 | 25.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 22 | 26 | $7,425 | $1,284 | 17.3% |
| 73502 | X-ray of hip, 2-3 views | Office | 2022 | 14 | 18 | $1,836 | $559.30 | 30.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 12 | 14 | $994.00 | $340.50 | 34.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 15 | 28 | $784.00 | $234.20 | 29.9% |
| 27447 | Repair of knee joint, lower or upper part of joint, inside and outside area | Office | 2021 | 20 | 22 | $77,220 | $21,749 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 42 | $16,674 | $3,725 | 22.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 63 | $17,010 | $3,331 | 19.6% |
| 73562 | X-ray of knee, 3 views | Office | 2021 | 76 | 110 | $9,680 | $3,072 | 31.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $9,450 | $2,539 | 26.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 35 | 44 | $12,375 | $2,010 | 16.2% |
| 73560 | X-ray of knee, 1 or 2 views | Office | 2021 | 62 | 79 | $6,004 | $1,909 | 31.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 27 | 28 | $3,192 | $1,056 | 33.1% |
About Dr. Brad Larson, MD
Dr. Brad Larson, MD is a Orthopaedic Surgery healthcare provider based in Logan, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396733507.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brad Larson, MD has received a total of $314,054 in payments from pharmaceutical and medical device companies, with $51,154 received in 2024. These payments were reported across 141 transactions from 13 companies. The most common payment nature is "" ($266,570).
As a Medicare-enrolled provider, Larson has provided services to 1,564 Medicare beneficiaries, totaling 1,972 services with total Medicare billing of $166,133. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Location Logan, UT
- Active Since 10/11/2005
- Last Updated 06/08/2016
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1396733507
Products in Payments
- NOVOCART 3D (Device) $304,335
- NOVOCART 3D (Biological) $5,310
- TRIATHLON (Device) $985.71
- Mako (Device) $704.68
- Anchorage (Device) $623.50
- ReUnion (Device) $502.07
- Variax (Device) $417.43
- Senza Spinal Cord Stimulation System (Device) $151.36
- ACCOLADE (Device) $110.78
- MAKO (Device) $89.90
- Reunion (Device) $77.72
- Taperloc (Device) $74.96
- TissueMend (Device) $58.25
- Regeneten (Device) $58.10
- Nalu Neurostimulation System (Device) $56.72
- MAGNETOM Free.Max (Device) $50.56
- MACI (Biological) $48.40
- LENS Surgical Imaging System (Device) $38.00
- AccuFill (Device) $35.53
- Makoplasty (Device) $31.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Orthopaedic Surgery Doctors in Logan
Edwin Goble, Md, MD
Orthopaedic Surgery — Payments: $1.1M
Dr. Gregory Hicken, M.d, M.D
Orthopaedic Surgery — Payments: $22,750
Dr. Eric Hooley, M.d, M.D
Orthopaedic Surgery — Payments: $13,504
Kimberly Souza, Md, MD
Orthopaedic Surgery — Payments: $13,026
Dr. Keith Nelson, M.d, M.D
Orthopaedic Surgery — Payments: $3,854
David Vaziri, Md, MD
Orthopaedic Surgery — Payments: $1,528